Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Nasopharyngeal carriage of Streptococcus pneumoniae among healthy children in Kassena-Nankana districts of Northern Ghana.

Tytuł:
Nasopharyngeal carriage of Streptococcus pneumoniae among healthy children in Kassena-Nankana districts of Northern Ghana.
Autorzy:
Narwortey DK; Navrongo Health Research Centre, Ghana Health Services, Biomedical Department, P.O. Box 114, Navrongo, Ghana. .; Department of Clinical Microbiology, School of Medicine and Dentistry, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana. .
Owusu-Ofori A; Department of Clinical Microbiology, School of Medicine and Dentistry, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Slotved HC; Department of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark.
Donkor ES; Department of Medical Microbiology, University of Ghana Medical School, Accra, Ghana.
Ansah PO; Navrongo Health Research Centre, Ghana Health Services, Biomedical Department, P.O. Box 114, Navrongo, Ghana.
Welaga P; Navrongo Health Research Centre, Ghana Health Services, Biomedical Department, P.O. Box 114, Navrongo, Ghana.
Agongo G; Navrongo Health Research Centre, Ghana Health Services, Biomedical Department, P.O. Box 114, Navrongo, Ghana.
Oduro AR; Navrongo Health Research Centre, Ghana Health Services, Biomedical Department, P.O. Box 114, Navrongo, Ghana.
Źródło:
BMC infectious diseases [BMC Infect Dis] 2021 Jul 08; Vol. 21 (1), pp. 661. Date of Electronic Publication: 2021 Jul 08.
Typ publikacji:
Journal Article
Język:
English
Imprint Name(s):
Original Publication: London : BioMed Central, [2001-
MeSH Terms:
Carrier State/*epidemiology
Nasopharynx/*microbiology
Pneumococcal Infections/*diagnosis
Pneumococcal Vaccines/*administration & dosage
Streptococcus pneumoniae/*isolation & purification
Carrier State/microbiology ; Child ; Child, Preschool ; Cross-Sectional Studies ; Female ; Ghana/epidemiology ; Humans ; Infant ; Latex Fixation Tests ; Male ; Pneumococcal Infections/epidemiology ; Pneumococcal Vaccines/immunology ; Prevalence ; Serogroup ; Streptococcus pneumoniae/immunology ; Vaccination
References:
BMC Infect Dis. 2013 Oct 22;13:490. (PMID: 24148091)
Sci Rep. 2018 Oct 15;8(1):15258. (PMID: 30323328)
Lancet Infect Dis. 2004 Mar;4(3):144-54. (PMID: 14998500)
BMC Infect Dis. 2017 Jan 5;17(1):25. (PMID: 28056828)
BMC Infect Dis. 2017 Feb 8;17(1):133. (PMID: 28178935)
Lancet. 2009 Sep 12;374(9693):893-902. (PMID: 19748398)
PLoS One. 2019 Jan 30;14(1):e0211838. (PMID: 30699198)
Sci Rep. 2017 Oct 16;7(1):13280. (PMID: 29038446)
Antimicrob Agents Chemother. 2012 Sep;56(9):4965-8. (PMID: 22751537)
J Clin Microbiol. 2013 Oct;51(10):3395-9. (PMID: 23824778)
PLoS One. 2013 Nov 21;8(11):e79880. (PMID: 24278203)
mBio. 2020 May 19;11(3):. (PMID: 32430472)
PLoS One. 2018 Nov 8;13(11):e0206728. (PMID: 30408061)
Int J Epidemiol. 2012 Aug;41(4):968-76. (PMID: 22933645)
Future Microbiol. 2008 Feb;3(1):23-30. (PMID: 18230031)
Pediatr Infect Dis J. 2013 Feb;32(2):e45-53. (PMID: 23080290)
Vaccine. 2013 Dec 17;32(1):165-79. (PMID: 24331112)
PLoS Med. 2010 Oct 05;7(10):. (PMID: 20957191)
Clin Microbiol Rev. 2016 Jul;29(3):525-52. (PMID: 27076637)
Scand J Infect Dis. 2010 Apr;42(4):254-9. (PMID: 20085428)
mBio. 2015 Sep 15;6(5):e00902-15. (PMID: 26374118)
Clin Infect Dis. 2009 Jul 15;49(2):e23-9. (PMID: 19522653)
Carbohydr Res. 2014 Jan 13;383:97-104. (PMID: 24334220)
J Infect Dis. 2007 Nov 1;196(9):1346-54. (PMID: 17922399)
BMC Pediatr. 2019 Sep 5;19(1):316. (PMID: 31488088)
Microb Drug Resist. 2015 Dec;21(6):636-42. (PMID: 26172078)
PLoS Genet. 2014 May 01;10(5):e1004300. (PMID: 24786281)
Iran Red Crescent Med J. 2011 May;13(5):328-33. (PMID: 22737489)
Lancet Glob Health. 2018 Jul;6(7):e744-e757. (PMID: 29903376)
Manag Care. 2000 Sep;9(9):49-52, 54, 56-7 passim. (PMID: 11116663)
Epidemiol Infect. 2012 Jul;140(7):1252-66. (PMID: 22040368)
Emerg Infect Dis. 2015 Nov;21(11):2040-4. (PMID: 26488415)
J Infect Dis. 2007 Nov 1;196(9):1282-4. (PMID: 17922390)
J Infect Dis. 2008 Apr 1;197(7):1016-27. (PMID: 18419539)
J Infect Dis. 2005 Jul 15;192(2):192-9. (PMID: 15962213)
Pediatr Infect Dis J. 2003 Feb;22(2):133-40. (PMID: 12586977)
BMC Infect Dis. 2016 Oct 18;16(1):575. (PMID: 27756235)
Emerg Microbes Infect. 2014 Jun;3(6):e39. (PMID: 26038742)
West Afr J Med. 2002 Jul-Sep;21(3):233-6. (PMID: 12744576)
PLoS Pathog. 2009 Jun;5(6):e1000476. (PMID: 19521509)
Lancet. 2011 Dec 3;378(9807):1962-73. (PMID: 21492929)
JAMA. 2007 Apr 25;297(16):1784-92. (PMID: 17456820)
Wkly Epidemiol Rec. 2007 Mar 23;82(12):93-104. (PMID: 17380597)
Contributed Indexing:
Keywords: Carriage; Non-vaccine serotypes; Northern Ghana; PCV-13; S. pneumoniae; Vaccine serotypes
Substance Nomenclature:
0 (13-valent pneumococcal vaccine)
0 (Pneumococcal Vaccines)
Entry Date(s):
Date Created: 20210708 Date Completed: 20210712 Latest Revision: 20240402
Update Code:
20240402
PubMed Central ID:
PMC8265090
DOI:
10.1186/s12879-021-06302-5
PMID:
34233627
Czasopismo naukowe
Background: Pneumococcal vaccine immunizations may be responsible for alterations in serotype epidemiology within a region. This study investigated the pneumococcal carriage prevalence and the impact of the 13-valent pneumococcal conjugate vaccine (PCV-13) on circulating serotypes among healthy children in Northern Ghana.
Methods: This was a cross sectional study conducted in the Kassena-Nankana districts of Northern Ghana from November to December during the dry season of 2018. Nasopharyngeal swabs collected from 193 participants were cultured per standard microbiological protocols and pneumococcal isolates were serotyped using the latex agglutination technique and the capsular Quellung reaction test. We examined for any association between the demographic characteristics of study participants and pneumococcal carriage using chi-square test and logistic regression.
Results: Of the 193 participants that were enrolled the mean age was 8.6 years and 54.4% were females. The carriage rate among the participants was 32.6% (63/193), and twenty different serotypes were identified. These included both vaccine serotypes (VT), 35% (7/20) and non-vaccine serotypes (NVT), 65% (13/20). The predominant serotypes (34 and 11A), both of which were NVT, accounted for a prevalence of 12.8%. PCV-13 covered only 35% of serotypes identified whiles 40% of serotypes are covered by PPV 23.
Conclusion: Post-vaccination carriage of S. pneumoniae is high and is dominated by non-vaccine serotypes. There is therefore a need for the conduct of invasive pneumococcal disease surveillance (IPD) to find out if the high non-vaccine serotype carriage translates to disease. And in addition, a review of the currently used PCV-13 vaccine in the country would be considered relevant.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies